Time limits apply in Virginia. Find out if you still qualify.
Quick Eligibility Review
Answer one question at a time. This usually takes under 2 minutes.
Check your eligibility — free
Answer 2-3 quick questions to review your potential case.
Verified against court and regulatory records · No upfront fees · Your information is never sold
Statute of limitations — Virginia
Virginia Code § 8.01-243 provides a 2-year statute of limitations for personal injury claims. The discovery rule applies where the injury was not immediately discoverable — the clock starts when the plaintiff knew or should have known that their infection was linked to a contaminated duodenoscope. Virginia does not have a general statute of repose for product liability claims against manufacturers.
2 years from discovery of duodenoscope-linked infection
Filing venue
Where to File in Virginia
Virginia duodenoscope cases may be filed in Circuit Courts in Fairfax County, Arlington County, or the City of Richmond, or in the U.S. District Courts for the Eastern or Western Districts of Virginia. Virginia's proximity to the FDA headquarters in Silver Spring, Maryland, means that regulatory documents and FDA personnel are readily accessible for discovery and testimony. Virginia applies a risk-utility analysis for design defect claims and follows the Daubert standard for expert testimony in federal court. The state's 2-year limitations period requires timely filing, but the discovery rule provides protection for patients who did not immediately connect their post-ERCP infection to the duodenoscope.
Virginia data
Exposure in Virginia
Major Virginia hospital systems performing high-volume ERCP procedures with Olympus duodenoscopes, including Inova, VCU Health, UVA Health, and Sentara
5+
Source: Virginia Hospital and Healthcare Association
Olympus's share of the U.S. duodenoscope market at the time of major outbreaks — Virginia hospitals, like most nationwide, had limited access to alternative devices
85%
Source: FDA Advisory Committee presentations
Mortality rate for CRE bloodstream infections — the type of superbug transmitted by contaminated Olympus duodenoscopes
40–50%
Source: CDC Antibiotic Resistance Threats Report
Keep reading